[go: up one dir, main page]

MXPA05005919A - Composiciones de ifosfamida para la administracion parenteral, y un proceso para su preparacion. - Google Patents

Composiciones de ifosfamida para la administracion parenteral, y un proceso para su preparacion.

Info

Publication number
MXPA05005919A
MXPA05005919A MXPA05005919A MXPA05005919A MXPA05005919A MX PA05005919 A MXPA05005919 A MX PA05005919A MX PA05005919 A MXPA05005919 A MX PA05005919A MX PA05005919 A MXPA05005919 A MX PA05005919A MX PA05005919 A MXPA05005919 A MX PA05005919A
Authority
MX
Mexico
Prior art keywords
preparation
compositions
parenteral administration
ifosfamide
ifosfamide compositions
Prior art date
Application number
MXPA05005919A
Other languages
English (en)
Inventor
Subbappa Praveen Kumar
Original Assignee
Bharat Serums & Vaccines Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bharat Serums & Vaccines Ltd filed Critical Bharat Serums & Vaccines Ltd
Publication of MXPA05005919A publication Critical patent/MXPA05005919A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/655—Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40—Cyclodextrins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6564—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms
    • C07F9/6581—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms
    • C07F9/6584—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having phosphorus atoms, with or without nitrogen, oxygen, sulfur, selenium or tellurium atoms, as ring hetero atoms having phosphorus and nitrogen atoms with or without oxygen or sulfur atoms, as ring hetero atoms having one phosphorus atom as ring hetero atom
    • C07F9/65842—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring
    • C07F9/65846—Cyclic amide derivatives of acids of phosphorus, in which one nitrogen atom belongs to the ring the phosphorus atom being part of a six-membered ring which may be condensed with another ring system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Saccharide Compounds (AREA)

Abstract

La presente invencion proporciona composiciones acuosas de ifosfamida y un proceso para su preparacion, en donde las composiciones tienen una toxicidad reducida sobre y antes del uso concomitante del agente uroprotector, Mesna. Las composiciones acuosas de ifosfamida se pueden preparar en una concentracion tan alta como de 1100 mg/ml.
MXPA05005919A 2002-12-02 2003-12-02 Composiciones de ifosfamida para la administracion parenteral, y un proceso para su preparacion. MXPA05005919A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN785MU2002 2002-12-02
PCT/IN2003/000376 WO2004050012A2 (en) 2002-12-02 2003-12-02 Ifosfamide compositions for parenteral administration and a process for their preparation

Publications (1)

Publication Number Publication Date
MXPA05005919A true MXPA05005919A (es) 2005-09-21

Family

ID=32448836

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA05005919A MXPA05005919A (es) 2002-12-02 2003-12-02 Composiciones de ifosfamida para la administracion parenteral, y un proceso para su preparacion.

Country Status (16)

Country Link
EP (1) EP1569663B1 (es)
JP (1) JP4611029B2 (es)
KR (1) KR101066181B1 (es)
CN (1) CN100463678C (es)
AT (1) ATE465744T1 (es)
AU (1) AU2003302579B2 (es)
BR (1) BR0316968A (es)
CA (1) CA2507848A1 (es)
DE (1) DE60332385D1 (es)
EA (1) EA012368B1 (es)
ES (1) ES2342380T3 (es)
IL (1) IL168849A (es)
MX (1) MXPA05005919A (es)
NZ (1) NZ540484A (es)
WO (1) WO2004050012A2 (es)
ZA (1) ZA200504437B (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2013501046A (ja) 2009-08-06 2013-01-10 ニューラルタス ファーマシューティカルズ， インコーポレイテッド マクロファージ関連障害の処置

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5356986A (en) * 1984-12-14 1986-07-22 Gergely, Gerhard Teilchen aus euner hydrophoben oder schwerloslichen substanz und verfahren zur ihrer hydrophilisierung
NO873860L (no) * 1986-10-31 1988-05-02 Asta Pharma Ag Ifosfamid-lyofilisat og fremgangsmaate til deres fremstilling.
US5002935A (en) * 1987-12-30 1991-03-26 University Of Florida Improvements in redox systems for brain-targeted drug delivery
DE58900183D1 (de) * 1988-03-19 1991-08-29 Asta Pharma Ag Ifosfamid-mesna-lyophilisat und verfahren zu dessen herstellung.
IE62095B1 (en) * 1988-03-29 1994-12-14 Univ Florida Pharmaceutical formulations for parenteral use
EP0491812A4 (en) * 1989-09-14 1992-11-04 Australian Commercial Research & Development Limited Drug delivery compositions
US5227373A (en) * 1991-10-23 1993-07-13 Bristol-Myers Squibb Co. Lyophilized ifosfamide compositions
ZA949182B (en) * 1993-12-02 1995-07-26 South African Druggists Ltd Pharmaceutical composition
DE19529057B4 (de) * 1995-08-08 2007-12-13 Baxter Healthcare S.A. Ifosfamid-Lyophilisat-Zubereitungen
AUPQ849900A0 (en) * 2000-06-30 2000-07-27 Dbl Australia Pty Ltd. Injectable composition
AU2002359695A1 (en) * 2001-12-13 2003-06-30 Sicor Inc. Aqueous ifosfamide composition
MXPA05002453A (es) * 2002-09-05 2005-05-27 Bharat Serums & Vaccines Ltd Composicion estable liquida de oxazafosforina con el 2-mercaptoetansulfonato de sodio.
US7199111B2 (en) * 2002-12-02 2007-04-03 Bharat Serums & Vaccines Ltd. Aqueous ifosfamide compositions for parenteral administration and a process for their preparations

Also Published As

Publication number Publication date
NZ540484A (en) 2008-03-28
EA200500763A1 (ru) 2006-12-29
AU2003302579A1 (en) 2004-06-23
JP4611029B2 (ja) 2011-01-12
EP1569663B1 (en) 2010-04-28
JP2006512329A (ja) 2006-04-13
AU2003302579B2 (en) 2008-09-18
WO2004050012A2 (en) 2004-06-17
CA2507848A1 (en) 2004-06-17
IL168849A (en) 2009-02-11
WO2004050012A3 (en) 2004-10-21
ATE465744T1 (de) 2010-05-15
KR20050089153A (ko) 2005-09-07
DE60332385D1 (de) 2010-06-10
EP1569663A4 (en) 2007-05-23
ES2342380T3 (es) 2010-07-06
CN1744904A (zh) 2006-03-08
EP1569663A2 (en) 2005-09-07
BR0316968A (pt) 2005-10-25
EA012368B1 (ru) 2009-10-30
CN100463678C (zh) 2009-02-25
ZA200504437B (en) 2006-07-26
KR101066181B1 (ko) 2011-09-20

Similar Documents

Publication Publication Date Title
MXPA03007837A (es) Composiciones para suministrar bisfosfonatos.
MY144992A (en) Substituted 1,2,3,4-tetrahydroisoquinoline derivatives.
MXPA04004567A (es) Compuestos y composiciones de fenoxi amina para adminstrar agentes activos.
AU7315301A (en) Compounds and compositions for delivering active agents
HRP20031003A2 (en) 4&#39;-substituted nukleosides
GEP20094845B (en) Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors
WO2004092135A3 (en) Substituted benzosulphonamide as potentiators of glutamate receptors
MXPA03007857A (es) Compuestos y composiciones para entregar agentes activos.
TW200700086A (en) Injectable non-aqueous suspension
MXPA05008368A (es) 1,2,4-triazinas inhibidoras del virus de inmunodeficiencia humana.
MY143795A (en) Tetrahydropyridoindole derivatives
WO2006116733A3 (en) Protein kinase inhibitors
WO2005030766A8 (en) Phenyl - carboxamide compounds useful for treating pain
TW200501965A (en) Highly pure fondaparinux sodium composition,process for preparing said composition and pharmaceutical compositions containing it as active principle
MX2008001560A (es) Nuevos compuestos analogos de la camptotecina, un procedimiento para su preparacion y composiciones farmaceuticas que los contienen.
WO2003063851A8 (en) Composition for pharmaceutical or dietetic use for combating hair loss
IL168718A (en) Biguanide derivatives, compositions comprising the derivatives, process for preparing an antimicrobial compound and use of the derivatives in the preparation of medicaments
UA93529C2 (ru) Соли и смеси 9-оксоакридин-10-уксусной кислоты c 1-алкиламино-1-дезоксиполиолами
IL186058A0 (en) Polymorphs of 3-0-(3&#39;,3&#39; -dimethylsuccinyl) betulinic acid di-n-methyl-d-glucamine salt
MX2010003594A (es) Formas cristalinas de sal sodica de dmxaa.
IL163608A (en) Sulfonanilides are conserved in their amino / amino acids and derivatives, their process, their pharmaceutical preparations, and their conjugated antibodies and their use in the preparation of drugs for the treatment of culture disorders
MXPA05008902A (es) Soluciones de drogas en mentol.
NZ523606A (en) Pharmaceutical compositions and methods for use
MXPA05005919A (es) Composiciones de ifosfamida para la administracion parenteral, y un proceso para su preparacion.
ATE412404T1 (de) Stabile orale pharmazeutische zusammensetzungen von buprenorphin und salz davon

Legal Events

Date Code Title Description
FG Grant or registration